VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1650823
Sex: M
Age:
State: PA

Vax Date: 03/24/2021
Onset Date: 04/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: lethargic; muscle aches; This is a spontaneous report from a contactable consumer. A 53-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Mar2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and pollen allergy. Prior to vaccination, the patient was diagnosed with COVID-19 on an unknown date. Concomitant medications included atorvastatin calcium (LIPITOR), lisinopril (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN), all for unknown indications on unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021 at 10:30, the patient experienced muscle aches and was lethargic. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lethargic and muscle aches was resolved on an unknown date in Apr2021.The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Apr2021 at 10:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LIPITOR; LISINOPRIL

Current Illness:

ID: 1650824
Sex: F
Age:
State: NJ

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Injection site pain; This is a spontaneous report from a contactable consumer. A 29-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 10:15 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included unspecified birth control medication from an unknown date for an unknown indication and unknown if ongoing. It was unknown if the patient was pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient experienced injection site pain. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event injection site pain was resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650825
Sex: F
Age:
State: LA

Vax Date: 03/30/2021
Onset Date: 04/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 37-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6205), at the age of 37, via an unspecified route of administration, left arm, on Mar 30, 2021, at 17:30, single dose, for COVID-19 immunisation. Medical history not reported. The patient has no allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medications included Contrave (naltrexone hydrochloride/bupropion hydrochloride), for an unknown indication; from an unknown date. Previously, patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6202), at the age of 37, via an unspecified route of administration, left arm, on Mar 9, 2021, at 16:30, single dose, for COVID-19 immunisation. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. On Apr 2, 2021, at 10:00, patient reported the Friday after receiving the second dose of the Pfizer COVID-19 vaccine, she broke-out in hives. The patient never had hives in her life. The only new thing she encountered recently was the vaccine. Therapeutic measures taken as a result of hives included treatment with Benadryl. Since the vaccination, patient has not tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event hives: not recovered (at the time of this report). No follow-up attempts needed. No further information expected.

Other Meds: Contrave

Current Illness:

ID: 1650826
Sex: M
Age:
State: TX

Vax Date: 04/08/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Date: 20210413; Test Name: Body temperature; Result Unstructured Data: Test Result:100.5 up 101.7; Comments: Fever from 100.5 up 101.7; Test Date: 20210416; Test Name: SARA-CoV2-test; Result Unstructured Data: Test Result:Pending; Comments: Nasal swab

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Fever from 100.5 up 101.7. Fever had been for 4 days continuously.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302), via an unspecified route of administration in the left arm on 08Apr2021 at 12:00 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. The patient previously took clarithromycin (BIAXIN) and azithromycin (MANUFACTURER UNKNOWN); both on unknown dates for unspecified indications and experienced drug allergy. On 13Apr2021 at 13:30, the patient experienced fever from 100.5 up 101.7. Fever had been for 4 days continuously. Therapeutic measures were not taken as a result of the event. On 13Apr2021 at 13:30, the patient underwent lab test and procedure which included body temperature and result was shown as from 100.5 up 101.7 (units unspecified). On 16Apr2021, the patient underwent SARS-CoV2-test (nasal swab) and the result was pending. The clinical outcome of the event fever from 100.5 up 101.7, fever had been for 4 days continuously was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650827
Sex: M
Age:
State: VA

Vax Date: 04/16/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: 2nd injection got numbness; face got itchy; then got red raised bumps on legs; sore throat and ears, pain in chest.; sore throat and ears, pain in chest.; sore throat and ears, pain in chest.; This is a spontaneous report from a contactable consumer or other non health care professional. A 41-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 16Apr2021 15:00 (Batch/Lot Number: EW0170) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. Concomitant medication included tizanidine (TIZANIDINE) taken for an unspecified indication, start and stop date were not reported. The patient experienced 2nd injection got numbness, face got itchy, then got red raised bumps on legs, sore throat and ears, pain in chest (non-serious) on unspecified date. The outcome of the events were recovered with sequelae. No follow-up attempts are needed as information about lot/batch number obtained.

Other Meds: TIZANIDINE

Current Illness:

ID: 1650828
Sex: F
Age:
State: GA

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Low grade fever; fatigue; dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 15Apr2021 at 17:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC) from an unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 03Mar2021 at 12:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 11:00, the patient experienced low grade fever, fatigue and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events low grade fever, fatigue and dizziness was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1650829
Sex: F
Age:
State: IL

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Left arm was so painful for almost 48 hours after the second dose; I could barely move the arm, making it difficult to dress/undress, put the arm on my chair's armrest, etc.; This is a spontaneous report from a non-contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm left on 15Apr2021 at 10:00 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 10:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an15Apr2021, the patient's left arm was so painful for almost 48 hours after the second dose and could barely move the arm, making it difficult to dress/undress, put the arm on the chair's armrest, etc. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm was so painful for almost 48 hours after the second dose and could barely move the arm, making it difficult to dress/undress, put the arm on the chair's armrest, etc. was recovered on 16Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650830
Sex: M
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: dizziness; rapid heart beat; This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 18:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Other medical history included food allergy and environmental allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced dizziness and rapid heartbeat lasted for 1 to 2 minutes. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of dizziness and rapid heartbeat was recovered on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650831
Sex: F
Age:
State: CA

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Tightness in chest; Weird heartbeat; Tingling/numbing sensation on face; Tingling/numbing sensation on face; Dizziness; Confused/trouble focusing; Confused/trouble focusing; Nausea; Pain at injection site; Chills; Headache; Itchy face; Tired; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 14:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and lower back pain. The patient had no other issues. The patient had latex allergy, no known allergies but suspected soft shell crab, shrimp allergy, allergy to something in some surgical masks and nitrile gloves ("must special order for work"), skin reaction and headaches to some fragrances, deodorants, lotions, etc. and potentially developing seasonal allergies recently. The patient had never tested for allergies. Concomitant medications included acetylsalicylic acid/ caffeine/ paracetamol (EXCEDRIN) for migraine on an unknown date and bismuth subsalicylate (PEPTO BISMOL) for an unknown indication from an unknown date; both were unknown if ongoing. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received flu vaccine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and experienced dizziness and nausea twice which passed within 15 minutes. On 15Apr2021 at 14:45, immediately after the vaccination, the patient experienced tightness in chest, weird heartbeat, tingling/numbing sensation on face, dizziness, confused/trouble focusing, nausea, pain at injection site and later the patient experienced chills, headache, nausea, itchy face, pain at injection site and was tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tightness in chest, weird heartbeat, tingling/numbing sensation on face, dizziness, confused/trouble focusing, nausea, pain at injection site, chills, headache, itchy face and tired were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]; PEPTO BISMOL [BISMUTH SUBSALICYLATE]

Current Illness:

ID: 1650832
Sex: F
Age:
State: MO

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Very sore arm.; Very very sleepy.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 08:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included estrogen (MANUFACTURER UNKNOWN) and phendimetrazine tartrate (BONTRIL), both taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 14:00, the patient experienced very sore arm and very very sleepy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events very sore arm and very very sleepy were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ESTROGEN NOS; BONTRIL

Current Illness:

ID: 1650833
Sex: F
Age:
State: MA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Stuffy nose; swollen lymph node under armpit of injection arm right arm could not sleep for 3 plus hours due to pain of swollen lymph node; Could not sleep for 3 plus hours; Woke up groggy; Intermittent sweats; overheating; Very tired; Arm/injection site soreness and pain lifting arm above head; Arm/injection site soreness and pain lifting arm above head; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0158) via an unspecified route of administration in the right arm on 14Apr2021 at 13:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and herpes simplex type ii (HSV2). The patient was allergic to sulfa meds. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), clonazepam (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the right arm on 25Mar2021 at 13:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, on day 1 of vaccination, the patient felt very tired, arm/injection site soreness, pain lifting arm above head. On 15Apr2021, on day 2 of vaccination, the patient was tired, had intermittent sweats/overheating. The patient had no fever or chills. On evening day 2 the patient fell asleep around 21:00 just tired, awake around 00:30 on 16Apr2021 with stuffy nose and swollen lymph node under armpit of injection arm (right arm); the patient couldn't sleep for 3+ hours due to pain of swollen lymph node, approximately size of clementine; eventually slept again, on day 3, 16Apr2021 the patient woke up groggy, alert but tiring easily as the patient tried to work (computer/office job from home). Lymph node swelling down considerably but not gone and still was painful. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very tired, arm/injection site soreness and pain lifting arm above head, intermittent sweats, overheating, woke up groggy, stuffy nose, swollen lymph node under armpit of injection arm right arm could not sleep for 3 plus hours due to pain of swollen lymph node were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN; CLONAZEPAM; PROZAC

Current Illness:

ID: 1650834
Sex: F
Age:
State: CA

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Date: 202104; Test Name: Heart rate; Result Unstructured Data: Test Result:85 bpm; Comments: Heart rate was elevated above 85bpm for most of the day with low to no movement; Test Date: 20210409; Test Name: Heart rate; Result Unstructured Data: Test Result:100 bpm; Test Date: 20210409; Test Name: Body temperature; Result Unstructured Data: Test Result:101 (unspecified units); Comments: Fever - began within 12 hours; highest temp recorded was 101?

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Fever - began within 12 hours; highest temp recorded was 101; Massive headache/migraine; Rapid heart rate - resting in middle of night was approx. 100bpm and is normally approx. 50-55bpm. Heart rate was elevated above 85bpm for most of the day with low to no movement; Dizziness and hard to talk from heart rate; Hard to talk from heart rate; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 08Apr2021 at 17:00 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included heart condition- congenital pulmonary stenosis and subclinical hypothyroidism. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included etonogestrel (NEXPLANON) and levothyroxine (MANUFACTURER UNKNOWN), all taken from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 18Mar2021 at 17:15 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 02:00, within 12 hours the patient experienced fever; highest temperature recorded was 101-degree, massive headache/migraine and rapid heart rate. Resting in middle of night was approx. 100 bpm and was normally approx. 50-55 bpm. Heart rate was elevated above 85bpm for most of the day with low to no movement. The patient also had dizziness and hard to talk from heart rate. On 09Apr2021 patient checked body temperature and resulted in 101 degree Fahrenheit and checked heart rate which was 100 beats per minute, and 85 beats per minute for most of the day with low or no movement. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever; highest temperature recorded was 101-degree, massive headache/migraine and rapid heart rate. Resting in middle of night was approx. 100 bpm and was normally approx. 50-55 bpm. Heart rate was elevated above 85bpm for most of the day with low to no movement. The patient also had dizziness and hard to talk from heart rate were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NEXPLANON; LEVOTHYROXINE

Current Illness:

ID: 1650835
Sex: F
Age:
State: WA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Chills; Fever; Body ache; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date and the patient did not have any other relevant medical history. The patient had no allergies to medications, food, or other products. The patient did not receive any medication within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 14:00, within several hours of vaccine dose, the patient experienced chills, fever and body ache, which lasted for one day and the patient was feeling better. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever and body ache were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650836
Sex: F
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Sore arm at injection site; Stomach cramps; Low-grade fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 18:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and sesame oil allergy. Concomitant medications included vitamin D nos (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), ubidecarenone (COQ-10) and prenatal vitamin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 17:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Apr2021 at 03:00, the patient experienced sore arm at injection site, stomach cramps and low-grade fever with chills. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sore arm at injection site, stomach cramps and low-grade fever with chills was resolving at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: VITAMIN D NOS; MAGNESIUM; COQ-10

Current Illness:

ID: 1650837
Sex: F
Age:
State: VA

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: About 3 hours after getting the vaccine, my tongue started to swell; My throat hurt; My throat hurt as well near the lymph nodes.; rash appeared on my neck; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW01J8) via an unspecified route of administration on 15Apr2021 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, known allergies to latex, pollen and ragweed. Concomitant medications included diphenhydramine, paracetamol, phenylpropanolamine hydrochloride (BENADRYL), fexofenadine hydrochloride (ALLEGRA) and unspecified vitamins; all for unspecified indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 16:30, about 3 hours after getting the vaccine, the patient experienced tongue started to swell and a rash appeared on neck and throat hurt as well near the lymph nodes. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events tongue started to swell and a rash appeared on neck and throat hurt as well near the lymph nodes and included treatment with prednisone. The clinical outcome of the events tongue started to swell and a rash appeared on neck and throat hurt as well near the lymph nodes were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: BENADRYL; ALLEGRA

Current Illness:

ID: 1650838
Sex: M
Age:
State:

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Brain fog; Migraine; Night sweats; Headache; Chills; Fever; Tired; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8735) via an unspecified route of administration in the arm left on 08Apr2021 at 11:45 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. On 09Apr2021 at 02:00, the patient experienced brain fog, migraine, night sweats, headache, chills, fever and tired. Therapeutic measures were taken as a result of events and included treatment with TYLENOL. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain fog, migraine, night sweats, headache, chills, fever and tired were recovered on an unspecified date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650839
Sex: F
Age:
State: WI

Vax Date: 03/28/2021
Onset Date: 03/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Body aches; Tired; Dizziness; Nausea; Taste metallic; It also felt tingly or spicy sensation; It also felt tingly or spicy sensation; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8733) via an unspecified route of administration in the left arm on 28Mar2021 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluticasone propionate (FLOVENT), olopatadine (MANUFACTURER UNKNOWN) and fluticasone (MANUFACTURER UNKNOWN); all for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 19:30, three hours after the shot, the patient experienced dizziness, nausea. The next day, on 29Mar2021, the patient was nauseated, had body aches and was tired. 1-2 days after, on an unknown date of Mar2021, the patient had a weird taste metallic in mouth and also felt tingly or spicy sensation. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness, nausea, body aches, tired, weird taste metallic in mouth and also felt tingly or spicy sensation was recovered on an unknown date in 2021. No follow-up attempts are possible. No further information is expected

Other Meds: FLOVENT; OLOPATADINE; FLUTICASONE

Current Illness:

ID: 1650840
Sex: F
Age:
State: AZ

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the left arm on 16Apr2021 at 08:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis and allergy to sulfa drugs. Concomitant medications included desvenlafaxine succinate monohydrate (PRISTIQ), bupropion (MANUFACTURER UNKNOWN), drospirenone, ethinylestradiol (GIANVI) and spironolactone (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 11:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 11:00, the patient experienced joint pain several hours after injections. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event joint pain was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: PRISTIQ; BUPROPION; GIANVI; SPIRONOLACTONE

Current Illness:

ID: 1650841
Sex: F
Age:
State: OK

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Long event of bruising/ bruises that do not hurt; Big purple spots; This is a spontaneous report from a contactable pharmacist, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on an unknown date and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3249) via an unspecified route of administration in the left arm on 16Jan2021 as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient had no known allergies. On an unknown date in 2021, the patient experienced long event of bruising and bruises that did not hurt and caused big purple spots and lasted for days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events long event of bruising/ bruises that do not hurt and big purple spots were resolved on an unknown date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650842
Sex: M
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Sore arm in day after dose; headaches in day after dose; This is a spontaneous report from a contactable consumer. A male adult patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced sore arm and headaches in day after dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm and headaches in day after dose were recovered on an unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650843
Sex: F
Age:
State: CA

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Backache; Chills; Slight headache; Feverish; Pins and needles all over body; This is a spontaneous report from a contactable healthcare professional. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:30 hours (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, cholesterol high, COVID-19 infection and right knee replacement. It was unknown if the patient had known allergies to medications, food or other products. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) 40 mg, for unknown indication, from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021 at 12:00, the patient experienced backache, chills, slight headache, feverish and pins and needles all over body. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events backache, chills, slight headache, feverish and pins and needles all over body was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL

Current Illness:

ID: 1650844
Sex: F
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Soreness in armpit (lymph nodes); This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6204) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021, the patient experienced soreness in armpit (lymph nodes). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the reported events. The clinical outcome of the event soreness in armpit (lymph nodes) was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650845
Sex: F
Age:
State: PA

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Fatigue; Slight headache; Arm sore at injection site; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 12Apr2021 at 11:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 22Mar2021 at 11:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. On 12Apr2021 at 14:45, the patient experienced fatigue which was going on day 4, slight headache and arm sore at injection site which resolved on day 02. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm sore at injection site was resolved on 14Apr2021. The clinical outcome of the events fatigue and slight headache were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650846
Sex: F
Age:
State: CA

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Fast heartbeat; Dizziness; Weakness / no energy; Diarrhea; Itch; Chills; Headache; Nausea; Eating any little food made me feel as if the food is at the top of my throat; Bodyache; This is a spontaneous report received from a contactable consumer or other non-health care professional (Patient). A 48-years-old female patient received unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on 15Apr2021 08:30 (at the age of 48-year-old) as dose number unknown, single for COVID-19 immunisation. Medical history included depression from an unknown date and unknown if ongoing. The patient previously took COMPAZINE [prochlorperazine edisylate] for hypersensitivity and experienced drug hypersensitivity. The patient received anti depressant within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered: Public Health Clinic/Veterans Administration facility. The patient experienced fast heartbeat, dizziness, weakness / no energy, diarrhoea, itch, chills, headache, nausea, eating any little food made me feel as if the food is at the top of my throat, bodyache on 15Apr2021. The events outcome was recovered with sequel on an unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650847
Sex: M
Age:
State: GA

Vax Date: 01/08/2021
Onset Date: 01/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: Blood test; Result Unstructured Data: Test Result:Normal; Comments: Blood work normal at annual wellness check.

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Swollen lymph nodes in the left inner arm pit/ swollen and non-painful lymph nodes on the left side the neck.; Painful lymph nodes in the left inner arm pit; This is a spontaneous report from a contactable other healthcare professional. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0140), via an unspecified route of administration in left arm on 08Jan2021 (at the age of 27-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0140), via an unspecified route of administration in the right arm on 29Jan2021 at 13:00 (at the age of 27-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. The patient did not receive any other medications in two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received unspecified vaccine within four weeks of vaccination. On 11Jan2021, the patient experienced swollen and painful lymph nodes in the left inner arm pit and also swollen and non-painful lymph nodes on the left side of the neck. All occurred within the first few days after the first vaccination dose. Swollen lymph nodes had not reduced in size (nearing four months later), although pain was gone in a few days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent lab tests and procedures which included blood test (blood work) and the result was normal. The clinical outcome of the events, swollen and painful lymph nodes in the left inner arm pit and swollen and non-painful lymph nodes on the left side of the neck were unknown at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650848
Sex: F
Age:
State: CA

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: Heart rate; Result Unstructured Data: Test Result:90-110 bpm; Comments: 90-110 bpm when resting; Test Date: 20210330; Test Name: Heart rate; Result Unstructured Data: Test Result:120 Units:{DF}; Comments: 120 bpm

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Several days after the second dose, my apple watch alerted me that my heart rate had sky rocketed to 120bpm for my resting pulse. Typically my heart rate is between 60-70bpm. It's now between 90-110bp; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN8730), via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other medications in two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199), via an unspecified route of administration in the left arm on 08Mar2021 at 14:45 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 16:00, several days after the second dose the patient's apple watch alerted her that the heart rate had sky rocketed to 120 beats per minute for the resting pulse. Typically, her heart rate was between 60-70 beats per minute. It was now between 90-110 beats per minute when resting. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. On 30Mar2021 at 16:00, the patient underwent lab test and procedure which included heart rate and result was shown as 120bpm. On an unknown date, the patient underwent lab test and procedure which included heart rate and result was shown as 90-110 bpm. The clinical outcome of the event heart rate had sky rocketed to 120 beats per minute for her resting pulse, typically, her heart rate was between 60-70 beats per minute, it was now between 90-110 beats per minute was not resolved at the time of reporting. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1650849
Sex: F
Age:
State: WV

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Injection site pain; Fatigue; fever; chills; headache; body aches; Nausea; vomiting; This is a spontaneous report from a contactable nurse, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 14Apr2021(at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced injection site pain, fatigue, fever, chills, headache, body aches, nausea, vomiting. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events injection site pain, fatigue, fever, chills, headache, body aches, nausea, vomiting was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650850
Sex: F
Age:
State: MN

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Chills; unwell; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 12Apr2021 at 14:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Other medical history of the patient was not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not received any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 12:00, the patient experienced chills and unwell. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of chills and unwell was recovered on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650851
Sex: F
Age:
State: CA

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Tongue had numbness peaking at 1/2 hour after injection; Sensation similar to slick plastic later resolving into what a burnt tongue feels like the day after burning.; This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0158) via an unspecified route of administration in the left arm on 15Apr2021 at 11:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had allergy to nightshade family of foods (food allergies), mycin family of antibiotics (antibiotic allergies), and imaging contrast dye (contrast media allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included loratadine (CLARITIN) for unknown indication since an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at the patient experienced tongue numbness peaking at half hour after injection which dissipated 3 hours later, and after 24 hours it was completely gone. The patient did not lose sense of taste and experienced a sensation similar to slick plastic later resolving into what a burnt tongue feels like the day after burning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the reported events. The clinical outcome of the events tongue numbness and burnt tongue was recovered on 16Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: CLARITIN [LORATADINE]

Current Illness:

ID: 1650852
Sex: F
Age:
State: HI

Vax Date: 04/08/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Itchy rash at injection site on arm approximately 4 inches around.; Red rash at injection site on arm approximately 4 inches around; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 08Apr2021 at 14:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included an allergy to mango skin/syrup, poison oak and poison ivy. The patient was prone to contact dermatitis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 15Apr2021 at 20:00, the patient experienced an itchy and red rash at injection site on arm approximately 4 inches around. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy and red rash at injection site on arm approximately 4 inches around were resolved with lasting effects on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1650853
Sex: F
Age:
State: WI

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Vertigo; very dry nasal; Stuffy nasal congestion; Severe chills; Body aches particularly in upper back and neck; Fatigue; Fever; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 13Apr2021 at 09:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Other medical history included aneurysm of ascending aorta and depression. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 23Mar2021 at 11:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient received unspecified other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 02:30, the patient experienced severe chills, body aches particularly in upper back and neck, fatigue and fever. On 15Apr2021, the patient experienced very dry, stuffy nasal congestion. On 16Apr2021, after woke up, the patient experienced vertigo. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported event(s) which included treatment with unspecified medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of severe chills, body aches particularly in upper back and neck, fatigue and fever was recovered on an unknown date in Apr2021 (lasted for 24 hours), while the outcome of the events of very dry nasal, stuffy nasal congestion and vertigo was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650854
Sex: F
Age:
State: MN

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: atopic dermatitis on the face, neck, and hands which became moderate to severe; red patches; bruised-around my face and neck; flared up eczema; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the arm left on 13Apr2021 at 17:45 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, type 2 diabetes mellitus, urticaria, atopic dermatitis and asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metformin (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), vitamin b12 nos (MANUFACTURER UNKNOWN) and iron (MANUFACTURER UNKNOWN) all from an unknown date and unknown if ongoing for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 23Mar2021 at 18:15 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 12:00, the patient had reported an underlying condition of atopic dermatitis on the face, neck, and hands which became moderate to severe in the morning after the second dose of vaccination. The patient had red patches that almost look bruised around the face and neck which were extremely dry, tight, and flaky, and dried up after minutes of applying thick lotion/cream. It flared up eczema and the patient had not experienced this severe reaction in over one year. There was with no changes in any products used or the diet of the patient. Therapeutic measures included treatment with unknown lotion/cream. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events atopic dermatitis on the face, neck and hands which became moderate to severe, red patches almost look bruised and flared up eczema was recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; LEVOTHYROXINE; VITAMIN B12 NOS; IRON

Current Illness:

ID: 1650855
Sex: M
Age:
State: OH

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 64, via an unspecified route of administration, right arm, on Apr 12, 2021, at 04:15, single dose, for COVID-19 immunisation. The patient did not have any reported medical history. The patient has no known allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medications included Nexium (esomeprazole magnesium) from an unknown date for unspecified indication. The patient previously received the first dose (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), via an unspecified route of administration, right arm, on Mar 22, 2021, at 00:15, single dose, for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On Apr 13, 2021, at 13:30, patient experienced headache, fever, chills and nausea. Since the vaccination, patient has not tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures taken as a result of the reported events. The clinical outcome of events headache, fever, chills and nausea resolved on an unknown date in Apr 2021. No follow-up attempts needed. Information about lot/batch number cannot be obtained.

Other Meds: Nexium

Current Illness:

ID: 1650856
Sex: F
Age:
State: CA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Warm at injection site; Headache; Body aches; Fatigue; The patient received second dose vaccination on 13Apr2021 (within 15 days); This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 16:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included aciclovir (ACYCLOVIR), emtricitabine, tenofovir disoproxil fumarate (TRUVADA) and acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 15:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 16:00, the patient experienced warm at injection site, headache, body aches and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events warm at injection site, headache, body aches and fatigue was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ACYCLOVIR [ACICLOVIR]; TRUVADA; EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]

Current Illness:

ID: 1650857
Sex: F
Age:
State: DC

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Shooting pains in right breast (opposite from the arm where the injection was received).; Uterine cramping; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 11:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included a known allergy to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified birth control medications (MANUFACTURER UNKNOWN) from an unknown date for birth control and an unknown if ongoing. The patient previously received ampicillin (MANUFACTURER UNKNOWN) and experienced a drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 07Apr2021 at 11:45, the patient reported that during the 30 minutes waiting time, she experienced uterine cramping. On 08Apr2021, the next morning after the patient received the vaccine, she experienced shooting pain in the right breast (opposite from the arm where the patient received the injection). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shooting pain in the right breast (opposite from the arm where the patient received the injection) was resolved on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650858
Sex: M
Age:
State:

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: This is a spontaneous report from a noncontactable consumer (patient). A 27-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0126), at the age of 27, via an unspecified route of administration, left arm, on Apr 15, 2021, at 09:00, single dose, for COVID-19 immunisation. Medical history not reported. Concomitant medications included Descovy (emtricitabine-tenofovir alafenamide fumarate) from an unknown date for unknown indication. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), via an unspecified route of administration, unknown site, on an unknown date, single dose, for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 15, 2021, at 18:15, patient experienced chills, aches and fatigue. No therapeutic measures taken as a result of the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit or emergency visit. Since the vaccination, patient has not tested for COVID-19. The outcome of chills, aches and fatigue: recovering (at the time of report). No follow-up attempts possible. No further information expected.

Other Meds: Descovy

Current Illness:

ID: 1650859
Sex: F
Age:
State:

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210225; Test Name: Body temperature; Result Unstructured Data: Test Result:99.8 Units:[degF]; Comments: 99.8F Fever

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: 99.8 F Fever; Chills; Nausea; Headache; Pain at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 25Feb2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On an unknown date in 2021, the patient experienced 99.8-degree Fahrenheit fever, chills, nausea, headache and pain at injection site. . On an unknown date in 2021, the patient underwent lab tests and procedures, which included test for body temperature and the result was 99.8 degrees Fahrenheit. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events 99.8-degree Fahrenheit fever, chills, nausea, headache and pain at injection site were unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650860
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210413; Test Name: COVID-19 PCR test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Fatigue; Muscle weakness; Muscle soreness; Painful injection site; Swelling at injection site; Chills; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration on an unknown date (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patients' medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date, the patient experienced fatigue, muscle weakness and soreness, painful swelling at injection site, chills and headache. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 13Apr2021, the patient underwent a PCR (polymerase chain reaction) (nasal swab) test and tested negative. The clinical outcome of the events fatigue. muscle weakness and soreness, painful swelling at injection site, chills, headache was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650861
Sex: F
Age:
State: TX

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: shiver like freezing cold was under 3 blankets and could not warm up.; pains at the lymph glands at underarms and necks.; Severe Migraine; heart palpitations; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: E46162) via an unspecified route of administration in the left arm on 15Apr2021 at 14:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included azithromycin (AZITHROMYCIN PACK); taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) taken for unknown indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6455) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021, the patient did shiver from 22:00 like freezing cold and was under 3 blankets and could not warm up. The patient had pains at the lymph glands at underarms and necks and severe migraine and heart palpitations. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pains at the lymph glands at underarms and necks, severe migraine and heart palpitations were not recovered at the time of this report while the event shiver like freezing cold was under 3 blankets and could not warm up was recovered on 16Apr2021 at 04:00. No follow-up attempts are needed. No further information is expected.

Other Meds: AZITHROMYCIN

Current Illness:

ID: 1650862
Sex: F
Age:
State: MI

Vax Date: 03/29/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Menstrual bleeding in post menopausal woman. For about 1 week after injection and then restarted 17 days after injection. Restart is heavier than initial. Today is 1st day of restart; This is a spontaneous report from a contactable consumer (patient). A 56-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: 8730), via an unspecified route of administration, administered in Left arm on 29Mar2021 18:30 at the age of 56-years-old as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. Facility type vaccine was pharmacy or drug store. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 31Mar2021, the patient experienced Menstrual bleeding in post-menopausal woman. For about 1 week after injection and then restarted 17 days after injection. Restart is heavier than initial. Today is 1st day of restart. No treatment was received for adverse event. The outcome of event was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650863
Sex: F
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: aches; mild headache; low grade fever; Chills; muscular soreness near shot site; Phantom aromas; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 16Apr2021 at 13:00(at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included catamenial epilepsy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN); both started on unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 24Mar2021 at 13:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient previously received phenobarbital (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 16Apr2021, the patient experienced muscular soreness near shot site and 6-10 hours later experienced phantom aromas later, on 17Apr2021, 18 hours after vaccination, the patient experienced mild headache and after 24 hours experienced low grade fever, chills and aches. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event muscular soreness near shot site, phantom aromas, mild headache, low grade fever, chills and aches were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1650864
Sex: F
Age:
State: FL

Vax Date: 04/14/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Quarter size hives or rash above butt, center, near tail bone; Quarter size hives or rash above butt, center, near tail bone; Joint pain; Tenderness; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 14Apr2021 at 09:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer survivor and it was stage 1 both breast and had double mastectomy in 2015. The patient's health checks on an unknown date with doctors and primary care were all good. The patient had no allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included anastrozole (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), 1 a day 50+ (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 24Mar2021 at 09:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, after several hours of her vaccinations, the patient experienced joint pain and tenderness which went away by next day. On 16Apr2021 at 15:00, around 48 hours after second dose of vaccine, the patient experienced quarter size hives or rash above her butt, center and near tail bone. There were also small bumps not with puss. It did not itch unless she itches it. The patient applied coconut oil on it. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events quarter size hives or rash above butt, center and near tail bone was resolving. The clinical outcome of the events joint pain and tenderness was resolved on an unknown date Apr2021. No follow-up attempts are required; No further information is expected

Other Meds: ANASTROZOLE; BUPROPION

Current Illness:

ID: 1650865
Sex: F
Age:
State: KS

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Approximately 2 inches from my injection site, I developed a blister.; This is a spontaneous report from a contactable nurse, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8725) via an unspecified route of administration in the right arm on 06Apr2021 at 16:15 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroid cancer, rheumatoid arthritis, COVID-19 and penicillin allergy. The patient previously received erythromycin (MANUFACTURER UNKNOWN), cephalosporins (MANUFACTURER UNKNOWN), for an unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient received unspecified medication within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. 07Apr2021 at 09:30 the patient experienced blister approximately 2 inches from her injection site. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event blister approximately 2 inches from her injection site was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650866
Sex: F
Age:
State: MI

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: After the first shot my right arm got numb and I got the shot in the left arm though; tingling in my fingers too; After the first shot my right arm got numb and I got the shot in the left arm though; tingling in my fingers too; This is a spontaneous report from a contactable consumer (patient). A 78-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection)(at the age of 78-years-old), dose 1 via an unspecified route of administration, administered in Arm Left on 02Mar2021 (Lot Number: EN6198) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that Couple of hours after (On 02Mar2021) the first shot her right arm got numb and she got the shot in the left arm though. And tingling in her fingers too. It was a few hours after she got the first shot on 02Mar2021, that is the first dose. Patient received second dose of BNT162B2 (Lot Number: ER2613) on 24Mar2021 for COVID-19 Immunization. Regarding treatment for numbness and tingling Consumer stated, No, it went away after a several hours she guesses. she went to bed and by morning she was fine. The outcome of the events was recovered on unspecified date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650867
Sex: F
Age:
State: PA

Vax Date: 04/10/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Vertigo and lightheaded ness starting 4 days after receiving vaccine; Vertigo and lightheaded ness starting 4 days after receiving vaccine; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 10Apr2021 at 09:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included colon cancer, asthma and fibromyalgia. The patient had known allergies to azithromycin (ZITHROMAX). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, 4 days after vaccination, the patient experienced vertigo and light-headedness. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vertigo and light-headedness was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650868
Sex: F
Age:
State: WA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: COVID-19 virus test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Consistent dry cough that happened right after the 2nd shot; Sore arm; Fatigue; This is a spontaneous report from a contactable healthcare professional. the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew 0153) via an unspecified route of administration in the left arm on 13Apr2021 at 19:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included depression, anxiety and post-traumatic stress disorder (c-ptsd). The patient had no known allergies to medications, food or other products. Concomitant medications included sertraline hydrochloride (ZOLOFT) and fexofenadine hydrochloride (ALLERFLEX) for unknown indications, from an unknown date and unknown if ongoing. Prior to the vaccination, the patient had not been diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep 7534) via an unspecified route of administration in the left arm on 23Mar2021 at 20:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 13Apr2021 at 20:00 right after the second shot patient experienced consistent dry cough. It is been three days now and it still had the cough, sore arm and fatigue had went away. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. Since the vaccination, the patient had been tested for COVID-19, which included COVID-19 virus test (nasal swab) on an unknown date and tested negative. The clinical outcome of the events sore arm and fatigue was recovered, on an unknown date in Apr2021. The clinical outcome of the event consistent dry cough that happened right after the second shot was not recovered, at this time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT; ALLERFEX

Current Illness:

ID: 1650869
Sex: F
Age:
State: IN

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Red rash on both thumbs and wrist and some in between some fingers; Red rash on both thumbs and wrist and some in between some fingers; Itching in the palms of hand.; Itching at the rash site.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included osteoarthritis, blood pressure high (high b/p), spinal stenosis. The patient had known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on an unknown date in 2021, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date in 2021, the patient experienced red rash on both thumbs and wrist. Some in between some fingers. Itching in the palms of hand and also itching at the rash site. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events which included treatment with triamcinolone acetonide cream 0.5% (MANUFACTURER UNKNOWN). The clinical outcomes of the events red rash on both thumbs and wrist. Some in between some fingers. Itching in the palms of hand. Also itching at the rash site were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650870
Sex: F
Age:
State:

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Body aches; Super hot; Cold chills; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 15Apr2021, the patient experienced cold chills, body aches, super hot, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of cold chills, body aches, super hot, headache and fatigue was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650871
Sex: F
Age:
State:

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210417; Test Name: body temperature; Result Unstructured Data: Test Result:101.9 (unspecified units)

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Fever (101.9 at highest); aches; chills; headache; extreme fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non -pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 10:15 (age at vaccination:43-years) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 11:30 (age at vaccination:43-years) as a single dose for COVID-19 immunisation. On 17Apr2021 the patient experienced Fever (101.9 at highest), aches, chills, headache, extreme fatigue. No therapeutic measures were taken as a result of event. On 17Apr2021 the patient checked his body temperature which was 101.9 degree Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event Fever (101.9 at highest), aches, chills, headache, extreme fatigue were not resolved at the time of this report No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650872
Sex: F
Age:
State: VA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Top lip discoloration; Top lip discoloration and swelling with a numbness; Top lip discoloration and swelling with a numbness; Discomfort on left side of neck; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 16Apr2021 at 12:15 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (PTSD). The patient received unspecified medications within two weeks of vaccination. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 26Mar2021 at 11:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 14:45, the patient experienced top lip discoloration and swelling with a numbness and discomfort on left side of neck. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events top lip discoloration and swelling with a numbness and discomfort on left side of neck was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am